Alliance Pharma (APH)

 36.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 38.50p
  • 52 Week Low: 23.00p
  • Currency: UK Pounds
  • Shares Issued: 248.57m
  • Volume: 29,967
  • Market Cap: £90.42m
  • RiskGrade: 80
  • Beta: 0.06

Latest ShareCast News

Hargreaves Lansdown Marketing Director reduces stake by 200,000 shares

By Natasha Roberts

Date: Friday 26 Oct 2012

A round-up of the biggest director deals today so far.

Alliance Pharma Regulatory News

AGM Statement 22-May-2013 07:00 RNS
CULS Conversion and Additional Listing 13-May-2013 13:22 RNS
CULS Conversion and Additional Listing 23-Apr-2013 14:36 RNS
CULS Conversion and Additional Listing 15-Apr-2013 12:13 RNS
Annual Report and Accounts 11-Apr-2013 15:37 RNS

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 38.50p
52 Week Low 23.00p
Volume 29,967
Shares Issued 248.57m
Market Cap £90.42m
Beta 0.06
RiskGrade 80

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% above the market average29.39% above the market average29.39% above the market average29.39% above the market average29.39% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average
Price Trend
24.33% above the market average24.33% above the market average24.33% above the market average24.33% above the market average24.33% above the market average
24.00% above the sector average24.00% above the sector average24.00% above the sector average24.00% above the sector average24.00% above the sector average
Income
20.42% above the market average20.42% above the market average20.42% above the market average20.42% above the market average20.42% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
54.27% below the market average54.27% below the market average54.27% below the market average54.27% below the market average54.27% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 12-Jun-13 05-Dec-12
Paid 11-Jul-13 15-Jan-13
Amount 0.55p 0.28p

Trades for 24-May-2013

Time Volume / Share Price
15:04 8,193 @ 36.61p
12:47 12,150 @ 36.71p
10:51 6,000 @ 36.19p
09:41 3,624 @ 36.20p

Alliance Pharma Key Personnel

CEO John Dawson
Finance Director Richard Wright

Top of Page